T1	Participants 26 43	Hodgkin's disease
T2	Participants 93 175	49 patients (22 women, 27 men, mean age 43.7 [21-65] years) with Hodgkin's disease
T3	Participants 230 360	5.37 (2-10) years after the end of chemotherapy (given according to the COPP/ABVD scheme, with or without mediastinal irradiation)
T4	Participants 1159 1211	successfully treated patients with Hodgkin's disease
